Copyright Reports & Markets. All rights reserved.

Global and Japan Cancer Tumor Profiling Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Next-generation Sequencing (NGS)
    • 1.2.3 Polymerase Chain Reaction (PCR)
    • 1.2.4 Immunohistochemistry (IHC)
    • 1.2.5 In Situ Hybridization (ISH)
    • 1.2.6 Microarray
    • 1.2.7 Others
  • 1.3 Market by Application
    • 1.3.1 Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2026
    • 1.3.2 Personalized Medicine
    • 1.3.3 Diagnostics
    • 1.3.4 Biomarker Discovery
    • 1.3.5 Prognostics
    • 1.3.6 Research Applications
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Tumor Profiling Market Perspective (2015-2026)
  • 2.2 Global Cancer Tumor Profiling Growth Trends by Regions
    • 2.2.1 Cancer Tumor Profiling Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cancer Tumor Profiling Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cancer Tumor Profiling Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cancer Tumor Profiling Players by Market Size
    • 3.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2015-2020)
    • 3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2015-2020)
  • 3.2 Global Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue
  • 3.4 Global Cancer Tumor Profiling Market Concentration Ratio
    • 3.4.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2019
  • 3.5 Key Players Cancer Tumor Profiling Area Served
  • 3.6 Key Players Cancer Tumor Profiling Product Solution and Service
  • 3.7 Date of Enter into Cancer Tumor Profiling Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Tumor Profiling Breakdown Data by Type (2015-2026)

  • 4.1 Global Cancer Tumor Profiling Historic Market Size by Type (2015-2020)
  • 4.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2021-2026)

5 Cancer Tumor Profiling Breakdown Data by Application (2015-2026)

  • 5.1 Global Cancer Tumor Profiling Historic Market Size by Application (2015-2020)
  • 5.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cancer Tumor Profiling Market Size (2015-2026)
  • 6.2 North America Cancer Tumor Profiling Market Size by Type (2015-2020)
  • 6.3 North America Cancer Tumor Profiling Market Size by Application (2015-2020)
  • 6.4 North America Cancer Tumor Profiling Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Cancer Tumor Profiling Market Size (2015-2026)
  • 7.2 Europe Cancer Tumor Profiling Market Size by Type (2015-2020)
  • 7.3 Europe Cancer Tumor Profiling Market Size by Application (2015-2020)
  • 7.4 Europe Cancer Tumor Profiling Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Cancer Tumor Profiling Market Size (2015-2026)
  • 8.2 China Cancer Tumor Profiling Market Size by Type (2015-2020)
  • 8.3 China Cancer Tumor Profiling Market Size by Application (2015-2020)
  • 8.4 China Cancer Tumor Profiling Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Cancer Tumor Profiling Market Size (2015-2026)
  • 9.2 Japan Cancer Tumor Profiling Market Size by Type (2015-2020)
  • 9.3 Japan Cancer Tumor Profiling Market Size by Application (2015-2020)
  • 9.4 Japan Cancer Tumor Profiling Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Cancer Tumor Profiling Market Size (2015-2026)
  • 10.2 Southeast Asia Cancer Tumor Profiling Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Cancer Tumor Profiling Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Cancer Tumor Profiling Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Qiagen N.V.
    • 11.1.1 Qiagen N.V. Company Details
    • 11.1.2 Qiagen N.V. Business Overview
    • 11.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction
    • 11.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2015-2020))
    • 11.1.5 Qiagen N.V. Recent Development
  • 11.2 Roche Molecular Systems Inc.
    • 11.2.1 Roche Molecular Systems Inc. Company Details
    • 11.2.2 Roche Molecular Systems Inc. Business Overview
    • 11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction
    • 11.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.2.5 Roche Molecular Systems Inc. Recent Development
  • 11.3 Abott Molecular
    • 11.3.1 Abott Molecular Company Details
    • 11.3.2 Abott Molecular Business Overview
    • 11.3.3 Abott Molecular Cancer Tumor Profiling Introduction
    • 11.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.3.5 Abott Molecular Recent Development
  • 11.4 Illumina Inc.
    • 11.4.1 Illumina Inc. Company Details
    • 11.4.2 Illumina Inc. Business Overview
    • 11.4.3 Illumina Inc. Cancer Tumor Profiling Introduction
    • 11.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.4.5 Illumina Inc. Recent Development
  • 11.5 NeoGenomics Laboratories
    • 11.5.1 NeoGenomics Laboratories Company Details
    • 11.5.2 NeoGenomics Laboratories Business Overview
    • 11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction
    • 11.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.5.5 NeoGenomics Laboratories Recent Development
  • 11.6 HTG Molecular Diagnostic
    • 11.6.1 HTG Molecular Diagnostic Company Details
    • 11.6.2 HTG Molecular Diagnostic Business Overview
    • 11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction
    • 11.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.6.5 HTG Molecular Diagnostic Recent Development
  • 11.7 Genomic Health Inc.
    • 11.7.1 Genomic Health Inc. Company Details
    • 11.7.2 Genomic Health Inc. Business Overview
    • 11.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction
    • 11.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.7.5 Genomic Health Inc. Recent Development
  • 11.8 Hologic Gen-Probe
    • 11.8.1 Hologic Gen-Probe Company Details
    • 11.8.2 Hologic Gen-Probe Business Overview
    • 11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction
    • 11.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.8.5 Hologic Gen-Probe Recent Development
  • 11.9 BD Biosciences
    • 11.9.1 BD Biosciences Company Details
    • 11.9.2 BD Biosciences Business Overview
    • 11.9.3 BD Biosciences Cancer Tumor Profiling Introduction
    • 11.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.9.5 BD Biosciences Recent Development
  • 11.10 Siemens Healthineers
    • 11.10.1 Siemens Healthineers Company Details
    • 11.10.2 Siemens Healthineers Business Overview
    • 11.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction
    • 11.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 11.10.5 Siemens Healthineers Recent Development
  • 11.11 Claris Life Sciences
    • 10.11.1 Claris Life Sciences Company Details
    • 10.11.2 Claris Life Sciences Business Overview
    • 10.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction
    • 10.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.11.5 Claris Life Sciences Recent Development
  • 11.12 Personal Genome Diagnostics, Inc.
    • 10.12.1 Personal Genome Diagnostics, Inc. Company Details
    • 10.12.2 Personal Genome Diagnostics, Inc. Business Overview
    • 10.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction
    • 10.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.12.5 Personal Genome Diagnostics, Inc. Recent Development
  • 11.13 Perthera, Inc.
    • 10.13.1 Perthera, Inc. Company Details
    • 10.13.2 Perthera, Inc. Business Overview
    • 10.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction
    • 10.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.13.5 Perthera, Inc. Recent Development
  • 11.14 Foundation Medicine, Inc
    • 10.14.1 Foundation Medicine, Inc Company Details
    • 10.14.2 Foundation Medicine, Inc Business Overview
    • 10.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction
    • 10.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.14.5 Foundation Medicine, Inc Recent Development
  • 11.15 V., Strand
    • 10.15.1 V., Strand Company Details
    • 10.15.2 V., Strand Business Overview
    • 10.15.3 V., Strand Cancer Tumor Profiling Introduction
    • 10.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.15.5 V., Strand Recent Development
  • 11.16 ApoCell
    • 10.16.1 ApoCell Company Details
    • 10.16.2 ApoCell Business Overview
    • 10.16.3 ApoCell Cancer Tumor Profiling Introduction
    • 10.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.16.5 ApoCell Recent Development
  • 11.17 Contextual Genomics
    • 10.17.1 Contextual Genomics Company Details
    • 10.17.2 Contextual Genomics Business Overview
    • 10.17.3 Contextual Genomics Cancer Tumor Profiling Introduction
    • 10.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.17.5 Contextual Genomics Recent Development
  • 11.18 Agendia
    • 10.18.1 Agendia Company Details
    • 10.18.2 Agendia Business Overview
    • 10.18.3 Agendia Cancer Tumor Profiling Introduction
    • 10.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.18.5 Agendia Recent Development
  • 11.19 GenScript
    • 10.19.1 GenScript Company Details
    • 10.19.2 GenScript Business Overview
    • 10.19.3 GenScript Cancer Tumor Profiling Introduction
    • 10.19.4 GenScript Revenue in Cancer Tumor Profiling Business (2015-2020)
    • 10.19.5 GenScript Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Cancer Tumor Profiling Scope and Market Size
    Cancer Tumor Profiling market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Tumor Profiling market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Next-generation Sequencing (NGS)
    Polymerase Chain Reaction (PCR)
    Immunohistochemistry (IHC)
    In Situ Hybridization (ISH)
    Microarray
    Others

    Market segment by Application, split into
    Personalized Medicine
    Diagnostics
    Biomarker Discovery
    Prognostics
    Research Applications

    Based on regional and country-level analysis, the Cancer Tumor Profiling market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Cancer Tumor Profiling market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Qiagen N.V.
    Roche Molecular Systems Inc.
    Abott Molecular
    Illumina Inc.
    NeoGenomics Laboratories
    HTG Molecular Diagnostic
    Genomic Health Inc.
    Hologic Gen-Probe
    BD Biosciences
    Siemens Healthineers
    Claris Life Sciences
    Personal Genome Diagnostics, Inc.
    Perthera, Inc.
    Foundation Medicine, Inc
    V., Strand
    ApoCell
    Contextual Genomics
    Agendia
    GenScript

    Buy now